Booting Earth Optimization System
Thank you for your patience. Your civilization is very important to us.
Meropenem
Treatment for Invasive Non-typhoidal Salmonella (iNTS)
Typical Dosage: 1g IV every 8 hours
Effectiveness
95%
Safety Score
65%
Clinical Trials
80
Participants
8K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
65
DangerousModerateSafe
Treatment Details
Dosage Range
1g IV every 8 hours
Time to Effect
1-2 days
Treatment Duration
7-14 days
Evidence Quality
MODERATEConfidence Score
85%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$2,000
Monitoring:$1,000
Side Effect Mgmt:$100
Total Annual:$3,100
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
GOODQALYs Gained
0.25
Outcome-Based Costs
Cost per Responder
$3,263
Cost per Remission
$3,263
Meropenem Outcomes
for Invasive Non-typhoidal Salmonella (iNTS)
Efficacy Outcomes
Overall Effectiveness
+95%
Response Rate
+95%
Remission Rate
+95%
Common Side Effects
Diarrhea
+4%
Nausea/Vomiting
+3%
Injection site reactions
+2%
Seizures
+0.1%
Sources:
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov